Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
09 sept. 2021 07h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
International Week of Deaf People- Doug Disraeli D.D.S. Teams Up with Individuals from the Deaf Community to Give Dental Tips to Providers
06 sept. 2021 06h00 HE
|
Doug Disraeli, D.D.S.
SAN DIEGO, Sept. 06, 2021 (GLOBE NEWSWIRE) -- In observance of International Week of Deaf People on September 20-26, 2021, Doug Disraeli D.D.S. collaborates with individuals in the Deaf Community to...
Otonomy to Participate in Two Upcoming Investor Conferences
02 sept. 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Decibel Therapeutics to Present at Upcoming Investor Conferences
02 sept. 2021 07h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore...
Otonomy Appoints Jill Broadfoot to Board of Directors
19 août 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
Decibel Therapeutics Appoints Cynthia Hu as Chief Legal Officer and Corporate Secretary
18 août 2021 07h30 HE
|
Decibel Therapeutics, Inc.
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and...
Decibel Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update
10 août 2021 07h30 HE
|
Decibel Therapeutics, Inc.
- Bolstered Board of Directors and Scientific Advisory Board with key appointments - - On track for anticipated 2022 milestones including submission of IND and/or CTA for DB-OTO and interim...
Otonomy Reports Second Quarter 2021 Financial Results and Provides Corporate Update
04 août 2021 16h16 HE
|
Otonomy, Inc.
OTO-313 Phase 2 trial in tinnitus ongoing with results expected in mid-2022OTO-413 Phase 1/2 trial expansion in hearing loss ongoing with results expected in mid-2022OTO-825 preclinical...
InnerScope Hearing Technologies (OTC: INND) Upgraded to Pink Current by OTC Markets
29 juil. 2021 08h00 HE
|
InnerScope Hearing Technologies, Inc.
ROSEVILLE, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope" or the “Company”), an emerging and disruptive leader in the...
Otonomy to Report Second Quarter 2021 Financial Results and Provide Corporate Update
28 juil. 2021 07h30 HE
|
Otonomy, Inc.
SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...